DSpace About DSpace Software 日本語

01 奈良県立医科大学 >
012 大学院 >
0122 学位請求論文 >
01221 博士論文(医学) >
2015年度 >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10564/3078

Title: Erythropoietin attenuates intestinal inflammation and promotes tissue regeneration.
Other Titles: エリスロポエチンによる腸管に対する抗炎症、組織再生効果
Authors: Nakamura, Shinji
Sho, Masayuki
Koyama, Fumikazu
Ueda, Takeshi
Nishigori, Naoto
Inoue, Takashi
Nakamoto, Takayuki
Fujii, Hisao
Yoshikawa, Shusaku
Inatsugi, Naoki
Nakajima, Yoshiyuki
Keywords: cytokine
inflammatory bowel disease
tissue regeneration
Issue Date: Sep-2015
Publisher: Taylor & Francis / Informa Healthcare
Citation: Scandinavian journal of gastroenterology Vol.50 No.9 p.1094-1102(2015 Sep)
Abstract: Background. The prevalence of inflammatory bowel disease (IBD) is increasing. Since patients usually need long-term treatment and suffer from reduced quality of life, there is a need to develop new therapeutic strategy. The aim of this study was to investigate the therapeutic potential of erythropoietin (EPO) for the treatment of IBD. Methods. Murine colitis was induced by 3.0% Dextran Sulfate Sodium (DSS). Recombinant human EPO (rhEPO) was given to evaluate the anti-inflammatory and regenerative effects on intestinal inflammation. The effect of rhEPO on human colon epithelial cells was also evaluated. Immunohistochemical analysis of EPO receptor was performed in human IBD tissues. Results. While about 62% of control mice with severe colitis induced by 5-day DSS died, 85% of mice treated with rhEPO survived. Histological analysis confirmed that EPO treatment reduced the colonic inflammation. Furthermore, EPO treatment significantly downregulated the local expressions of IFN-γ, TNF-α and E-selectin in the colon, suggesting that the effect was associated with inhibiting local immune activation. In a 4-day DSS-induced colitis model, rhEPO significantly improved the recovery of body weight loss compared to controls. Furthermore, proliferating cell nuclear antigen expression was significantly upregulated in the colon tissue from mice treated with rhEPO compared to controls. In addition, rhEPO increased the growth of cultured human colon epithelial cells in a dose-dependent manner. Furthermore, EPO-receptor expression was confirmed in human IBD colon tissues. Conclusion. Three major functions of EPO, hematopoiesis, anti-inflammation and regeneration, may produce significant effects on intestinal inflammation, therefore suggesting that rhEPO might be useful for IBD.
Description: 博士(医学)・乙第1364号・平成27年7月31日
© Informa UK Limited, an Informa Group Company
The definitive version is available at " http://dx.doi.org/10.3109/00365521.2015.1020861 "
URI: http://hdl.handle.net/10564/3078
ISSN: 00365521
Academic Degrees and number: 24601B1364
Degree-granting date: 2015-07-31
Degree name: 博士(医学)
Degree-granting institutions: 奈良県立医科大学
Appears in Collections:2015年度

Files in This Item:

File Description SizeFormat
01_乙1364本文の要旨.pdf乙1364本文の要旨316.69 kBAdobe PDFView/Open
02_乙1364審査要旨.pdf乙1364審査要旨373.44 kBAdobe PDFView/Open
03_乙1364本文.pdf乙1364本文2.46 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback